FDA Approves Cannabis Study for PTSD in Veterans, Potentially Boosting Cannabis Stocks
The FDA has approved a study examining cannabis's therapeutic effects on 320 veterans with moderate to severe PTSD, a condition affecting roughly 7% of U.S. veterans.
FDA Approves Landmark Cannabis Study for PTSD Treatment in Veterans
The FDA has approved a study examining cannabis's therapeutic potential for treating post-traumatic stress disorder (PTSD) in 320 veterans.
FDA Approves Phase 2 Clinical Trial of Smoked Marijuana for PTSD in Veterans
The FDA has approved a Phase 2 clinical trial to evaluate smoked marijuana for treating PTSD in veterans, funded by Michigan cannabis sales tax revenue.
FDA Clears Phase 2 Trial of Smoked Cannabis for PTSD in Veterans
The FDA has cleared a Phase 2 trial to evaluate smoked cannabis in 320 veterans with moderate-to-severe PTSD who have prior cannabis use.